Q3 2026 13F filing
Updated 10 days ago113 disclosed positions worth $4.2B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | S Scholar Rock Holding Corporation | $453M | 9.38M | 10.71% | — |
| 2 | K Kymera Therapeutics, Inc. | $311.3M | 2.78M | 7.36% | — |
| 3 | E Erasca, Inc. | $193.5M | 13.20M | 4.57% | — |
| 4 | R Revolution Medicines, Inc. | $174.5M | 850.0K | 4.12% | — |
| 5 | B BeOne Medicines AG | $170.2M | 465.0K | 4.02% | — |
| 6 | T Tango Therapeutics, Inc. | $169.3M | 6.78M | 4.00% | — |
| 7 | M Veradermics, Incorporated | $160.5M | 1.32M | 3.79% | — |
| 8 | A Arrowhead Pharmaceuticals, Inc. | $149.9M | 2.29M | 3.54% | — |
| 9 | E Edgewise Therapeutics, Inc. | $113.8M | 2.80M | 2.69% | — |
| 10 | R Rhythm Pharmaceuticals, Inc. | $103.4M | 1.09M | 2.44% | — |
| 11 | B Bicara Therapeutics Inc | $102.4M | 5.50M | 2.42% | — |
| 12 | P Parabilis Medicines Inc | $96.6M | 2.99M | 2.28% | — |
| 13 | L Lexicon Pharmaceuticals, Inc. | $83.3M | 44.30M | 1.97% | — |
| 14 | S Spyre Therapeutics Inc | $77.3M | 868.6K | 1.83% | — |
| 15 | T Tyra Biosciences, Inc. | $74.3M | 3.40M | 1.76% | — |
| 16 | C Hemab Therapeutics Holdings Inc | $73M | 2.37M | 1.72% | — |
| 17 | A Amylyx Pharmaceuticals, Inc. | $72.2M | 2.48M | 1.71% | — |
| 18 | E Enliven Therapeutics, Inc. | $67.6M | 1.48M | 1.60% | — |
| 19 | S Septerna, Inc. | $66.5M | 1.70M | 1.57% | — |
| 20 | R Relay Therapeutics, Inc. | $58.9M | 3.26M | 1.39% | — |
| 21 | I Disc Medicine, Inc. | $58.2M | 888.4K | 1.37% | — |
| 22 | S Solid Biosciences Inc | $55.6M | 7.69M | 1.31% | — |
| 23 | S Stoke Therapeutics, Inc. | $51.9M | 2.00M | 1.23% | — |
| 24 | C Cogent Biosciences, Inc. | $51.5M | 1.61M | 1.22% | — |
| 25 | T Taysha Gene Therapies, Inc. | $48M | 9.85M | 1.13% | — |
| 26 | C Cytokinetics, Incorporated | $46.7M | 709.0K | 1.10% | — |
| 27 | R Arcus Biosciences, Inc. | $45.1M | 1.75M | 1.07% | — |
| 28 | O Olema Pharmaceuticals, Inc. | $42M | 4.86M | 0.99% | — |
| 29 | D Dyne Therapeutics, Inc. | $39.1M | 2.43M | 0.92% | — |
| 30 | A ADARx Pharmaceuticals, Inc. | $38.4M | 1.93M | 0.91% | — |
| 31 | R Remitly Global Inc | $32.9M | 1.54M | 0.78% | — |
| 32 | O ORIC Pharmaceuticals, Inc. | $31.7M | 2.35M | 0.75% | — |
| 33 | S Silence Therapeutics PLC | $31.6M | 2.89M | 0.75% | — |
| 34 | A Ascendis Pharma A/S | $29.6M | 130.0K | 0.70% | — |
| 35 | D Denali Therapeutics Inc. | $28.9M | 1.40M | 0.68% | — |
| 36 | P Palvella Therapeutics Inc | $28.6M | 207.5K | 0.68% | — |
| 37 | D Dbv Technologies SA | $27.7M | 2.36M | 0.65% | — |
| 38 | C Cullinan Therapeutics, Inc. | $27.5M | 1.79M | 0.65% | — |
| 39 | G Alphabet Inc. | $27.5M | 80.0K | 0.65% | — |
| 40 | G Structure Therapeutics Inc. | $27.3M | 873.0K | 0.65% | — |
| 41 | X Xenon Pharmaceuticals Inc. | $26.7M | 718.3K | 0.63% | — |
| 42 | K Kailera Therapeutics Inc | $25.3M | 2.21M | 0.60% | — |
| 43 | A Agenus Inc | $24M | 2.42M | 0.57% | — |
| 44 | N NVIDIA Corporation | $22.3M | 97.5K | 0.53% | — |
| 45 | S Seaport Therapeutics Inc | $22.1M | 1.10M | 0.52% | — |
| 46 | T Trevi Therapeutics, Inc. | $21.8M | 1.52M | 0.52% | — |
| 47 | R Rapport Therapeutics, Inc. | $21.6M | 641.5K | 0.51% | — |
| 48 | M Monopar Therapeutics Inc. | $21.5M | 270.1K | 0.51% | — |
| 49 | T Taiwan Semiconductor Manufacturing Company Limited | $20.5M | 45.0K | 0.49% | — |
| 50 | ? N/A Damora Therapeutics Inc | $19.2M | 900.0K | 0.45% | — |